We performed a copy number variation (CNV) assay to assess the EGFR amplification status in 69 primary GBM (here defined as brain tumors, BT) and in corresponding neurospheres (here defined as NS), cultured in the presence of EGF and bFGF. Here, FGF2 is linked to glioblastoma.